Home>Clinical research>Clinical trials by disease>Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

How to use the speech recognition tool?

NCT01367444

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration.

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2011-05-15
  • Closing Date: 2019-05-15

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: